2021

Home ▶ Washington Letter ▶ 2021 ▶ NIH Receives $1.2 Billion Funding Increase for 2021
NIH Receives $1.2 Billion Funding Increase for 2021

Just prior to the December holidays, Congress passed a legislative package that included all government spending for fiscal year (FY) 2021 and a COVID-19 response bill. After several days, President Trump signed the legislation into law on Dec. 27, 2020.

The FY2021 spending law includes a $1.250, or about 3 percent funding increase for the NIH for total funding of $42.9 billion in 2021. CDC received a $125 million funding increase, for total funding of $7.9 billion in FY2021. CDC will receive additional funding in 2021 under the COVID response law. In another win for respiratory health, the FY2021 spending law creates a new chronic disease education and awareness program at CDC, funded at $1.5 million, to support public health efforts to address COPD and other chronic diseases.

The FY2021 measure includes the following for NIH, CDC, EPA and other respiratory-related programs that the ATS monitors:

NIH

  • $3.66 billion for the NHLBI, an increase of $40.55 million over FY2020
  • $6.07 billion for the NIAID, an increase of $184.15 million over FY 2020
  • $814.68 million for the NIEHS, an increase of $12.1 million over FY 2020
  • $6.56 billion for the NCI, an increase of $119.41 million over FY 2020
  • $174.96 million for the NINR, an increase of $5.84 million over FY 2020
  • $390.87 million for the NIMHD, an increase of $55.1 million over FY 2020

CDC

  • $1.5 million for a new Chronic Disease Education and Awareness program, an increase of $1.5 million over FY 2020
  • $30 million for Asthma, stagnant at the FY2020 funding level
  • $10 million for Climate and Health, stagnant at the FY2020 funding level
  • $237.5 million for Tobacco, an increase of $7.5 million over FY 2020
  • $135 million for domestic Tuberculosis, stagnant at the FY2020 funding level
  • $345.3 million for the NIOSH, an increase of $2.5 million over FY 2020
  • $9 million for CDC’s global TB program, an increase of $2 million over FY2020

EPA

  • $9.24 billion for the EPA, an increase of $180 million over FY 2020

VA

  • $815 million for the VA Medical and Prosthetic Research Program, an increase of $15 million over FY 2020

Global Health

  • $319 million for Tuberculosis, a $9 million funding increase over FY 2020.
Last Reviewed: January 2021